Human Aldo-Keto Reductase Family 1 Member C3 (AKR1C3) Enzyme

Este producto es parte de AKR1C- Aldo-keto reductase family 1 member C
Human Aldo-Keto Reductase Family 1 Member C3 (AKR1C3) Enzyme
234€ (5 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Human Aldo-Keto Reductase Family 1 Member C3 (AKR1C3) Enzyme
Category
Proteins and Peptides
Provider
Abbexa
Reference
abx073557
Tested Applications
SDS-PAGE

Description

Aldo-Keto Reductase Family 1 Member C3 is a recombinant enzyme.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Proteins and Peptides
Immunogen Target
Aldo-Keto Reductase Family 1 Member C3 (AKR1C3)
Host
E. coli
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Origin
Human
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Size 1
5 µg
Size 2
20 µg
Size 3
1 mg
Form
Liquid
Tested Applications
SDS-PAGE
Availability
Shipped within 5-10 working days.
Storage
Store at 4°C if the entire vial will be used within 2-4 weeks. Store at -20 °C for long term storage. For long term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P42330
Alias
AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS
Background
Protein AKR1C3
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

AKR1C3, also known as 17β-hydroxysteroid dehydrogenase type 5, is a multifunctional enzyme involved in the metabolism of steroid hormones, prostaglandins, and xenobiotics. AKR1C3 converts androstenedione to testosterone and estrone to estradiol, playing a central role in androgen and estrogen biosynthesis. It also reduces prostaglandin D2 to PGF2α, influencing inflammation, immune responses, and cell proliferation. AKR1C3 is overexpressed in hormone-dependent cancers, such as prostate, breast, and endometrial cancers, where it promotes tumor growth by enhancing local androgen and estrogen production. Its ability to detoxify lipid peroxidation products like 4-HNE also confers resistance to oxidative stress and chemotherapy. AKR1C3 is emerging as a therapeutic target in cancer, particularly in castration-resistant prostate cancer, where it sustains androgen receptor signaling. In addition to cancer, AKR1C3 regulates neurosteroids and prostaglandin pathways, linking it to inflammation, neuroprotection, and metabolic diseases.

Productos relacionados

abx001477

Aldo-Keto Reductase Family 1 Member C3 (AKR1C3) Antibody

AKR1C3 Antibody is a Rabbit Polyclonal antibody against AKR1C3. AKR1C3(Aldo-keto reductase family 1 member C3) is also n…

Ver producto
abx025612

Aldo-Keto Reductase Family 1 Member C3 (AKR1C3) Antibody

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and prot…

Ver producto
abx026368

Aldo-Keto Reductase Family 1 Member C3 (AKR1C3) Antibody

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and prot…

Ver producto